Skip to main content
logo
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
31.86
-1.43 (-4.30%)
Sep 10, 2026, 4:00 PM EDT - Market closed

vTv Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
36.84-1.02-2.024.01
Revenue Growth
216600.00%----49.61%-37.56%
Gross Profit
8.16-17.86-10.53-13.6-10.34-8.62
Operating Income
-9.25-32.81-24.18-25.5-22.54-20.06
Net Income
-4.76-26.97-18.46-20.25-19.16-12.99
Earnings Per Share
-0.42-3.20-3.20-9.71-9.98-8.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
86.6488.9336.759.5112.1413.52
Total Debt
--0.170.530.720.93
Net Cash (Debt)
86.6488.9336.588.9811.4312.58
Net Cash Growth
235.27%143.14%307.23%-21.38%-9.20%141.84%
Net Cash Per Share
7.6410.566.344.315.958.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-16.76-25.26-25.31-19.08-16.02-19.31
Capital Expenditures
-----0.02-
Free Cash Flow
-16.76-25.26-25.31-19.08-16.04-19.31
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
22.16%-----215.21%
Operating Margin
-25.11%--2377.58%--1116.95%-500.92%
Pretax Margin
-17.38%--2222.71%--1232.56%-439.85%
Profit Margin
-12.91%--1815.34%--949.65%-324.27%
FCF Margin
-45.50%--2488.40%--795.00%-482.10%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.75-89.38-26.7616.63